Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Expert Review of Clinical Immunology|June 11, 2019
Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseasesKonstantinos Papamichael, Erik H Vogelzang, Jo Lambert, et al.
Inflammatory Bowel Diseases|May 3, 2018
Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's DiseaseKonstantinos Papamichael, Shana Rakowsky, Claudio Rivera, et al.
Inflammatory Bowel Diseases|August 18, 2017
Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug WindowKonstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, et al.
Expert Review of Gastroenterology & Hepatology|November 15, 2025
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
Therapeutic Advances in Chronic Disease|April 3, 2019
Infliximab in inflammatory bowel diseaseKonstantinos Papamichael, Steve Lin, Matthew Moore, et al.
Annals of Gastroenterology|October 2, 2015
Simethicone adjunct to polyethylene glycol improves small bowel capsule endoscopy imaging in non-Crohn's disease patientsKonstantinos Papamichael, Pantelis Karatzas, Ioannis Theodoropoulos, et al.
The American Journal of Gastroenterology|January 9, 2023
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH TrialAdam S Cheifetz, Niels Vande Casteele, Zhongya Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2024
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's DiseaseKonstantinos Papamichael, Andrea Centritto, Lucas Guillo, et al.
World Journal of Gastroenterology|August 23, 2018
Osteoporosis in primary biliary cholangitisChristopher J Danford, Hirsh D Trivedi, Konstantinos Papamichael, et al.
Pageof 15